Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients
Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
This Phase 2 study is a 8-site, double-blind, randomised, placebo-controlled, 3-way
cross-over trial, involving 3 treatments with Modafinil 300 mg or the combination drug THN102
(Modafinil/Flecainide 300 /3 mg, Modafinil/Flecainide 300 /27 mg).